KF
SEEL

Krilogy Financial’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Krilogy Financial’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– – – 713
2018
Q3 		– Hold
0
– – – 840
2018
Q2 		– Hold
0
– – – 656
2018
Q1 		– Hold
0
– – – 822
2017
Q4 		– Hold
0
– – – 850
2017
Q3 		– Hold
0
– – – 853
2017
Q2 		– Hold
0
– – – 785
2017
Q1 		– Hold
0
– – – 725
2016
Q4 		– Hold
0
– – – 770
2016
Q3 		– Hold
0
– – – 715

Other funds holding SEEL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return